Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.
Lykos shores up commercial team for MDMA drug; Former J&J CEO Alex Gorsky finds his next gig
Lykos Therapeutics is on a journey to get the first MDMA-assisted PTSD therapy approved by the FDA, and the biotech has tapped two new leaders
May 11, 2024